- XBiotech Inc XBIT shares surged 58.4 percent to $5.07 after falling 66.03 percent on Friday.
- GTx, Inc. GTXI shares jumped 49.1 percent to $4.62 after the company disclosed positive preliminary results from ongoing Phase 2 proof-of-concept clinical trial in women with stress urinary incontinence.
- Wecast Network Inc WCST rose 19.5 percent to $2.76 as the company disclosed that it has acquired 51 percent of NextGen Exchange Group.
- TrovaGene Inc TROV shares climbed 19.1 percent to $0.962 after the company reported a deal with AstraZeneca for utilization of Trovera ctDNA test and services in prospective biomarker study.
- Cellect Biotechnology Ltd. APOP shares surged 10.9 percent to $8.43 as the company disclosed that it has received a notice of allowance from the US PTO related to ApoGraft.
- First South Bancorp, Inc. FSBK shares gained 9.5 percent to $15.98 after Carolina Financial Corporation agreed to acquire First South Bancorp.
- Ascena Retail Group Inc ASNA shares rose 9 percent to $2.39
- Jumei International Holding Ltd(ADR) JMEI shares climbed 8.6 percent to $2.77 after declining 0.39 percent on Friday.
- XOMA Corporation XOMA gained 6.6 percent to $6.83. H.C. Wainwright initiated coverage of XOMA with a Buy rating.
- Qiwi PLC QIWI shares rose 5.3 percent to $24.78 after gaining 0.09 percent on Friday.
- Whiting Petroleum Corp WLL climbed 5.3 percent to $6.39 after gaining 6.68 percent on Friday.
- CACI International Inc CACI gained 4.5 percent to $128.95. Cowen & Co. upgraded CACI International from Market Perform to Outperform.
- Plug Power Inc PLUG shares rose 4.4 percent to $2.13 after declining 4.67 percent on Friday.
- General Electric Company GE rose 3.7 percent to $28.97 after the company announced the retirement of its CEO Jeff Immelt. GE named John Flannery as its new CEO.
- argenx SE ARGX shares gained 3.4 percent to $20.75. JMP Securities initiated coverage on argenx with a Market Outperform rating, while Cowen & Co. initiated coverage on the stock with an Outperform rating.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
